Biosimilars: A New Generation of Biologics

0 avg rating
( 0 ratings by Goodreads )
 
9782817803357: Biosimilars: A New Generation of Biologics

Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and price competition are expected throughout the world. However, due to the intrinsic heterogeneity and molecular complexity of biologic medicinal products, their copies cannot simply be authorized under the “generic rule” valid for small chemical entities.

 

In response, a dedicated regulation was issued in the European Union. It is based on the concept of “biological medicinal products similar to a biological reference product”, or “biosimilars”. This book analyses the context of biotechnological production and addresses the European legal framework for biosimilar market approval. It highlights post-market authorisation issues, such as Risk Management Plans and substitution of products, and outlines some other issues, such as cost management and international nomenclature.

 

This book is primarily intended for hospital-based physicians and pharmacists. It will also be a valuable resource for all actors from all countries who want to better understand the emergence of these new medicinal products within the European context.

"synopsis" may belong to another edition of this title.

About the Author:

Jean-Louis Prugnaud is a pharmacist, former head of pharmacy department at Saint-Antoine Hospital, Paris, France. He is Member of the French Commission of drugs’ distribution authorization, President of the Commission of gene and cellular therapy and President of the pharmaceutical working group on biological and biothechnological drugs. Jean-Hugues Trouvin works at AFSSAPS (French health products safety agency) and at the pharmaceutical and biological sciences department at the Paris Descartes University in Paris, France. Preface: Christian K. Schneider is Chairman, CHMP of the Similar Biological (Biosimilar) Medicinal Products Working Party (BMWP), member of the European Medicines Agency( London, United Kingdom) and works at the Paul-Ehrlich-Institut, Federal Agency for Sera and Vaccines (Langen, Germany) and at the Centre for Experimental and Clinical Infection Research (Hannover, Germany).

"About this title" may belong to another edition of this title.

Top Search Results from the AbeBooks Marketplace

1.

Published by Springer (2012)
ISBN 10: 2817803353 ISBN 13: 9782817803357
New Hardcover Quantity Available: 1
Seller:
Irish Booksellers
(Rumford, ME, U.S.A.)
Rating
[?]

Book Description Springer, 2012. Hardcover. Book Condition: New. book. Bookseller Inventory # M2817803353

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 31.48
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

2.

Published by Springer (2017)
ISBN 10: 2817803353 ISBN 13: 9782817803357
New Hardcover Quantity Available: 2
Print on Demand
Seller:
Murray Media
(North Miami Beach, FL, U.S.A.)
Rating
[?]

Book Description Springer, 2017. Hardcover. Book Condition: New. Never used! This item is printed on demand. Bookseller Inventory # P112817803353

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 78.55
Convert Currency

Add to Basket

Shipping: US$ 1.99
Within U.S.A.
Destination, Rates & Speeds

3.

Jean-Louis Prugnaud
Published by Springer Editions (2012)
ISBN 10: 2817803353 ISBN 13: 9782817803357
New Quantity Available: > 20
Print on Demand
Seller:
Pbshop
(Wood Dale, IL, U.S.A.)
Rating
[?]

Book Description Springer Editions, 2012. HRD. Book Condition: New. New Book.Shipped from US within 10 to 14 business days.THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Bookseller Inventory # IP-9782817803357

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 149.13
Convert Currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, Rates & Speeds

4.

Prugnaud, Jean-Louis
Published by Springer (2016)
ISBN 10: 2817803353 ISBN 13: 9782817803357
New Paperback Quantity Available: 1
Print on Demand
Seller:
Ria Christie Collections
(Uxbridge, United Kingdom)
Rating
[?]

Book Description Springer, 2016. Paperback. Book Condition: New. PRINT ON DEMAND Book; New; Publication Year 2016; Not Signed; Fast Shipping from the UK. No. book. Bookseller Inventory # ria9782817803357_lsuk

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 148.22
Convert Currency

Add to Basket

Shipping: US$ 5.17
From United Kingdom to U.S.A.
Destination, Rates & Speeds

5.

Jean-Louis Prugnaud, Jean-Hugues Trouvin
Published by Springer 2012-11-21 (2012)
ISBN 10: 2817803353 ISBN 13: 9782817803357
New Quantity Available: 3
Seller:
Chiron Media
(Wallingford, United Kingdom)
Rating
[?]

Book Description Springer 2012-11-21, 2012. Book Condition: New. Brand new book, sourced directly from publisher. Dispatch time is 24-48 hours from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely. Bookseller Inventory # NU-LBR-01134955

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 154.45
Convert Currency

Add to Basket

Shipping: US$ 3.98
From United Kingdom to U.S.A.
Destination, Rates & Speeds

6.

Prugnaud, Jean-Louis
Published by Springer Editions (2013)
ISBN 10: 2817803353 ISBN 13: 9782817803357
New Quantity Available: > 20
Print on Demand
Seller:
Books2Anywhere
(Fairford, GLOS, United Kingdom)
Rating
[?]

Book Description Springer Editions, 2013. HRD. Book Condition: New. New Book. Delivered from our US warehouse in 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND.Established seller since 2000. Bookseller Inventory # IP-9782817803357

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 152.96
Convert Currency

Add to Basket

Shipping: US$ 11.99
From United Kingdom to U.S.A.
Destination, Rates & Speeds

7.

Jean-Louis Prugnaud (editor), Jean-Hugues Trouvin (editor)
Published by Springer Paris 2012-11-21, Paris |London (2012)
ISBN 10: 2817803353 ISBN 13: 9782817803357
New Hardcover Quantity Available: 10
Seller:
Blackwell's
(Oxford, OX, United Kingdom)
Rating
[?]

Book Description Springer Paris 2012-11-21, Paris |London, 2012. hardback. Book Condition: New. Bookseller Inventory # 9782817803357

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 166.06
Convert Currency

Add to Basket

Shipping: US$ 8.00
From United Kingdom to U.S.A.
Destination, Rates & Speeds

8.

JEAN-LOUIS PRUGNAUD
Published by Springer (2012)
ISBN 10: 2817803353 ISBN 13: 9782817803357
New Hardcover Quantity Available: 1
Seller:
Herb Tandree Philosophy Books
(Stroud, GLOS, United Kingdom)
Rating
[?]

Book Description Springer, 2012. Hardback. Book Condition: NEW. 9782817803357 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. For all enquiries, please contact Herb Tandree Philosophy Books directly - customer service is our primary goal. Bookseller Inventory # HTANDREE0312469

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 169.10
Convert Currency

Add to Basket

Shipping: US$ 10.66
From United Kingdom to U.S.A.
Destination, Rates & Speeds

9.

Prugnaud, Jean-Louis [Editor]; Trouvin, Jean-Hugues [Editor];
Published by Springer (2012)
ISBN 10: 2817803353 ISBN 13: 9782817803357
New Hardcover Quantity Available: 10
Seller:
Ergodebooks
(RICHMOND, TX, U.S.A.)
Rating
[?]

Book Description Springer, 2012. Hardcover. Book Condition: New. Bookseller Inventory # INGM9782817803357

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 182.97
Convert Currency

Add to Basket

Shipping: US$ 4.99
Within U.S.A.
Destination, Rates & Speeds

10.

Jean-Louis Prugnaud
Published by Springer-Verlag Gmbh Nov 2012 (2012)
ISBN 10: 2817803353 ISBN 13: 9782817803357
New Quantity Available: 1
Seller:
Rating
[?]

Book Description Springer-Verlag Gmbh Nov 2012, 2012. Buch. Book Condition: Neu. Neuware - Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and price competition are expected throughout the world. However, due to the intrinsic heterogeneity and molecular complexity of biologic medicinal products, their copies cannot simply be authorized under the 'generic rule' valid for small chemical entities. In response, a dedicated regulation was issued in the European Union. It is based on the concept of 'biological medicinal products similar to a biological reference product', or 'biosimilars'. This book analyses the context of biotechnological production and addresses the European legal framework for biosimilar market approval. It highlights post-market authorisation issues, such as Risk Management Plans and substitution of products, and outlines some other issues, such as cost management and international nomenclature. This book is primarily intended for hospital-based physicians and pharmacists. It will also be a valuable resource for all actors from all countries who want to better understand the emergence of these new medicinal products within the European context. 87 pp. Englisch. Bookseller Inventory # 9782817803357

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 181.56
Convert Currency

Add to Basket

Shipping: US$ 14.10
From Germany to U.S.A.
Destination, Rates & Speeds

There are more copies of this book

View all search results for this book